We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.94%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$54.2B
AUM Growth
+$30.1B
(+125%)
Cap. Flow
+$28.6B
Cap. Flow
% of AUM
52.81%
Top 10 Holdings %
Top 10 Hldgs %
15.56%
Holding
4,600
New
1,635
Increased
1,281
Reduced
635
Closed
782
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.08B |
| 2 |
Amazon
AMZN
|
+$1B |
| 3 |
Meta Platforms (Facebook)
META
|
+$844M |
| 4 |
Apple
AAPL
|
+$842M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$725M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$192M |
| 2 |
West Pharmaceutical
WST
|
+$107M |
| 3 |
Advanced Micro Devices
AMD
|
+$97.2M |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
+$79.3M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$79.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.77% |
| 2 | Healthcare | 17.47% |
| 3 | Financials | 15.58% |
| 4 | Consumer Discretionary | 12.3% |
| 5 | Communication Services | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Vaalco Energy
EGY
$559M
| $915K | ﹤0.01% |
+285,349
| New | +$947K |
|
2502
Pilgrim's Pride
PPC
$7.1B
| $906K | ﹤0.01% |
32,125
+7,663
| +31% | +$218K |
|
2503
Quad
QUAD
$480M
| $905K | ﹤0.01% |
226,104
-46,620
| -17% | -$191K |
|
|
ATAQ.WS
2504
CALL
DELISTED
Altimar Acquisition Corp III Warrants
ATAQ.WS
| $905K | ﹤0.01% |
92,743
| – | – |
|
2505
Ginkgo Bioworks
DNA
$517M
| $899K | ﹤0.01% |
+2,706
| New | +$1.29M |
|
2506
TFI International
TFII
$11.7B
| $899K | ﹤0.01% |
8,015
-29,670
| -79% | -$3.23M |
|
2507
CALL
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
| $899K | ﹤0.01% |
23,000
-127,100
| -85% | -$5M |
|
|
ZUO
2508
DELISTED
Zuora, Inc.
ZUO
| $899K | ﹤0.01% |
+48,126
| New | +$967K |
|
2509
Neurocrine Biosciences
NBIX
$18.4B
| $898K | ﹤0.01% |
+10,553
| New | +$971K |
|
2510
Saratoga Investment
SAR
$311M
| $897K | ﹤0.01% |
+30,523
| New | +$888K |
|
|
RAM
2511
DELISTED
Aries I Acquisition Corporation Class A Ordinary Share
RAM
| $897K | ﹤0.01% |
89,613
| – | – |
|
2512
Rafael Holdings
RFL
$102M
| $896K | ﹤0.01% |
+178,430
| New | +$2.4M |
|
|
ONIT
2513
Onity Group
ONIT
$346M
| $896K | ﹤0.01% |
+22,403
| New | +$756K |
|
2514
Emergent Biosolutions
EBS
$383M
| $893K | ﹤0.01% |
20,519
-102,200
| -83% | -$4.62M |
|
2515
Village Farms International
VFF
$242M
| $888K | ﹤0.01% |
+138,278
| New | +$1.02M |
|
|
WKME
2516
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $886K | ﹤0.01% |
+45,124
| New | +$1.01M |
|
|
APEN
2517
DELISTED
Apollo Endosurgery, Inc.
APEN
| $882K | ﹤0.01% |
104,666
-44,356
| -30% | -$387K |
|
2518
StepStone Group
STEP
$3.58B
| $880K | ﹤0.01% |
+21,149
| New | +$934K |
|
2519
PUT
iShares MSCI Turkey ETF
TUR
$201M
| $877K | ﹤0.01% |
47,200
+3,300
| +8% | +$68.2K |
|
2520
Anterix
ATEX
$1.77B
| $872K | ﹤0.01% |
+14,854
| New | +$902K |
|
|
CTLT
2521
DELISTED
CATALENT, INC.
CTLT
| $868K | ﹤0.01% |
+6,787
| New | +$872K |
|
2522
CBAK Energy Technology Ltd
CBAT
$43.1M
| $862K | ﹤0.01% |
552,429
+491,602
| +808% | +$1.01M |
|
2523
Leggett & Platt
LEG
$1.41B
| $861K | ﹤0.01% |
20,921
-11,089
| -35% | -$482K |
|
2524
Salesforce
CRM
$155B
| $859K | ﹤0.01% |
3,381
-98,890
| -97% | -$27.8M |
|
|
EXPR
2525
DELISTED
Express, Inc.
EXPR
| $856K | ﹤0.01% |
+13,901
| New | +$1.09M |
|
Similar funds
Marshall Wace's Q4 2021 Portfolio in Review
As of Q4 2021, Marshall Wace held 4,600 positions worth $54.2B, up 125% from $24.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $28.6B of net new capital in Q4 2021, opening 1,635 new positions and adding to 1,281 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Accenture, an estimated $192M trimmed.
- Marshall Wace's largest Q4 2021 buy was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
- Marshall Wace added most to Microsoft in Q4 2021, an estimated $1.08B increase.
- Marshall Wace's biggest Q4 2021 reduction was Accenture, cutting an estimated $192M.
- Marshall Wace fully exited Sabre in Q4 2021, selling an estimated $44.1M.
- Marshall Wace's ten largest holdings make up 16% of its $54.2B portfolio in Q4 2021.
- Marshall Wace opened 1,635 new positions and closed 782 in Q4 2021.
- Marshall Wace's portfolio value rose 125% quarter-over-quarter to $54.2B.
Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.